Description
LUMINEX LX200 LAB SYSTEM
First action · last action
2013-09-30 · 2020-07-21
Transactions
2
First transaction's obligation
$74,032
Base + all options value (sum of deltas)
$74,031
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-09-30+$74,032= $74,032
- Mod P000012020-07-21-$1= $74,031
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-09-30 | +$74,032 | $74,032 | LUMINEX LX200 LAB SYSTEM |
| Mod P00001· FUNDING ONLY ACTION | 2020-07-21 | −$1 | $74,031 | LUMINEX LX200 LAB SYSTEM |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI VLLHHV5E3AL1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726P0700 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · J066 · MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT | $7,790 | FY2026 |
| 36C24126N0575 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $93,749 | FY2026 |
| 36C24426N0663 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $121,316 | FY2026 |
| 36C24526F0002 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $41,461 | FY2026 |
| 36C24425N0821 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $121,316 | FY2025 |
| 36C24125N0845 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $95,000 | FY2025 |
Other recipients under 6640 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126N0704 | FISHER SCIENTIFIC COMPANY L.L.C. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $44,786 | FY2026 |
| 36C26126P1003 | ELITECHGROUP INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $16,591 | FY2026 |
| 36C26126P1059 | INNOVIVE, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $25,251 | FY2026 |
| 36C26126F0354 | GOVERNMENT SCIENTIFIC SOURCE INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $188,181 | FY2026 |
| 36C26126N0439 | SYSMEX AMERICA, INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $193,194 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26113P3249_3600_-NONE-_-NONE- · retrieved 2026-09-26.